These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Paroxetine for treatment of obsessive-compulsive disorder and comorbid stuttering. Murray MG; Newman RM Am J Psychiatry; 1997 Jul; 154(7):1037. PubMed ID: 9210761 [No Abstract] [Full Text] [Related]
28. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309 [TBL] [Abstract][Full Text] [Related]
29. Reactivity of serotonin in whole blood. Mulder EJ; Anderson GM; Kema IP; Minderaa RB Biol Psychiatry; 2002 Feb; 51(3):266-8. PubMed ID: 11839371 [No Abstract] [Full Text] [Related]
30. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs? Komaroff AL Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725 [No Abstract] [Full Text] [Related]
31. Paroxetine use in medically ill patients. Stout SS; Somerset WI; Miller A; Musselman DL Psychopharmacol Bull; 2003; 37 Suppl 1():108-22. PubMed ID: 14566206 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents]. Bailly D Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324 [TBL] [Abstract][Full Text] [Related]
33. A review of pharmacologic treatments for obsessive-compulsive disorder. Kaplan A; Hollander E Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138 [TBL] [Abstract][Full Text] [Related]
34. Withdrawal syndrome associated with abrupt discontinuation of SSRIs. Wincor MZ J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961 [No Abstract] [Full Text] [Related]
35. Successful treatment of severe antidepressant-induced nausea with a combination of milnacipran and olanzapine. Yoshida K; Higuchi H; Ozaki N Pharmacopsychiatry; 2007 Mar; 40(2):84-5. PubMed ID: 17447181 [No Abstract] [Full Text] [Related]
36. Association of paroxetine with suicide attempt in obsessive-compulsive disorder. Göder R; Friege L; Treskov V; Grohmann R; Aldenhoff JB Pharmacopsychiatry; 2000 May; 33(3):116-7. PubMed ID: 10855464 [No Abstract] [Full Text] [Related]
37. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience. DeVane CL; Sallee FR J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970 [TBL] [Abstract][Full Text] [Related]